Whitehouse Station, NJ, United States of America

Yuting Tang

This inventor holds 1 USPTO granted patent. Top assignee: Ortho-Muniel Pharmaceutical, Inc.. Active years: 2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yuting Tang. Retrieved from https://idiyas.com/inventor/yuting-tang-9izvero9

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yuting Tang: Innovator in Therapeutic Methods

Introduction

Yuting Tang is a notable inventor based in Whitehouse Station, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel therapeutic methods.

Latest Patents

Yuting Tang holds 1 patent for his invention titled "Arylindenopyridines and related therapeutic and prophylactic methods." This invention provides novel arylindenopyridines of a specific formula and pharmaceutical compositions that are useful for treating disorders by antagonizing Adenosine A2a receptors or reducing PDE activity in appropriate cells. The invention also outlines therapeutic and prophylactic methods utilizing these pharmaceutical compositions.

Career Highlights

Yuting Tang is currently associated with Ortho-Muniel Pharmaceutical, Inc., where he continues to innovate in the pharmaceutical sector. His work focuses on developing new therapeutic solutions that can improve patient outcomes.

Collaborations

Some of his notable coworkers include Geoffrey R. Heintzelman and Kristin M. Averill, who contribute to the collaborative efforts in their research and development projects.

Conclusion

Yuting Tang's innovative work in the field of pharmaceuticals highlights his commitment to advancing therapeutic methods. His contributions are paving the way for new treatments that can significantly impact healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…